FDA issues more diabetes drug warnings
May 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Boehringer, J&J, JJ, lilly
The FDA has warned that a class of type 2 diabetes drugs manufactured by several big pharma firms could cause …
Boehringer widens IPF drug’s reach
May 18, 2015Sales and Marketing Boehringer, Esbriet, ats, brett wells, nintedanib, ofev
Boehringer Ingelheim has highlighted new data for its idiopathic pulmonary fibrosis (IPF) treatment Ofev in a Phase II study on …
Takeda appoints new business unit director
May 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, craig adkins
Takeda UK has appointed Craig Adkins as the new director of its its inflammatory bowel disease (IBD) business unit. Adkins …
The EU Falsified Medicines Directive: what does pharma need patients to know?
May 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eu falsified, waarde
Recent legislation assumes that visual information can have direct effects on people’s behaviour. It starts from the assumption that a …
Merck KGaA reveals ASCO plans
May 15, 2015Sales and Marketing ASCO, Merck, Merck KGaA, Merck Serono, avelumab
Merck KGaA is the latest company to announce its slate for this year’s ASCO conference, and like other firms it …
Teva lifted by positive migraine drug results
May 15, 2015Sales and Marketing TEV-48125, Teva, headaches, migraine
Patients who take either dose of Teva’s investigational treatment for chronic migraine improve more than those taking a placebo according …
London hospital pilots Apple watch app in chemotherapy
May 15, 2015Medical Communications, Sales and Marketing Apple, King’s College Hospital, brett wells, chemo, medopad, watch, wearables
King’s College Hospital in London is piloting a scheme whereby cancer patients moving through chemotherapy treatments are given an Apple …
Virgo Health Education announces new senior team
May 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo Health Education
Virgo Health Education has appointed a new head of medical education and announced a number of senior team promotions. Katherine …
AstraZeneca eyes success in immuno-oncology combinations
May 14, 2015Sales and Marketing ASCO, AZ, AstraZeneca, CTLA-4, MEDI4736
An investigational immuno-oncology drug combination from AstraZeneca has shown promise in its most recent trial, although concerns over its side …
Survey reveals pharma’s most reputable companies
May 14, 2015Medical Communications, Sales and Marketing Novartis, nayer, reputation
Bayer has held on to the top spot in a global survey of how much the general public trusts and …
Roche lung cancer treatments perform
May 14, 2015Sales and Marketing MPDL3280A, Roche, alectinib, immunotherapy
Roche has revealed promising trial data from two lung cancer treatments with one improving survival and the other shrinking tumours. …
Takeda hits major snags with Contrave and Alisertib
May 14, 2015Sales and Marketing Contrave, Takeda, alisertib, obesity, orexigen
Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …
OrthoAccel Technologies appoints new board member
May 14, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OrthoAccel Technologies, len hedge
US-based medical device firm OrthoAccel Technologies has announced that Len Hedge has joined its board of directors. Hedge currently serves on the …
UK doctors urged to curb overtreatment
May 13, 2015Sales and Marketing Academy of Medical Royal Colleges, BMJ, NHS, uk doctors
The UK’s body of medical colleges has launched a new campaign to warn of the dangers of over-treating patients with …
AstraZeneca makes a move into precision medicine
May 13, 2015Research and Development, Sales and Marketing AstraZeneca, Precision Medicine, cardiovascular diseases, diabetes, mhi
AstraZeneca has signalled its intention to ramp up the use of personalised medicine strategies to find new candidate drugs and …
Baxter buys cancer portfolio for $900 million
May 13, 2015Research and Development, Sales and Marketing Cancer, Oncaspar, Sigma-Tau Finanziaria, baxter, oncology
Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …
Applied Proteomics hires commercial VP
May 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Applied Proteomics, Erwin Estigarribia
San Diego’s Applied Proteomics that develops protein-based molecular diagnostics has confirmed the appointment of Erwin Estigarribia as the VP of …
Scottish Medicines Consortium approves seven drugs
May 12, 2015Sales and Marketing NHS, SMC, Scottish Medicines Consortium
The Scottish Medicines Consortium has accepted seven new medicines and indications for use on the NHS in Scotland. Two of …
Pharma reveals its ASCO presentation data
May 12, 2015Research and Development, Sales and Marketing ASCO, AZ, AbbVie, Roche, chicago, data
AstraZeneca, Genentech and AbbVie have all revealed which cancer drugs they will show data for at The American Society of …
Pharma M&A trail continues as Pfizer buys slice of Dutch biotech
May 12, 2015Sales and Marketing Endo, Pfizer, aspen, merger
Pfizer has acquired a minority equity interest in the biotech firm AM-Pharma, and secured an exclusive option to acquire the …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
